Pharmaceuticals, Biotechnology and Life Sciences
Analysis shows combinatorial approach is more effective than single-gene testing at predicting sertraline metabolism in patients with major depressive disorderSALT LAKE…
Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue of $2.8 Million, an 18%…
Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter and $194.7 million for full year 2021, a…
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of 2022 — — Proof-of-Concept Study…
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — Cytek® Biosciences, Inc. (“Cytek…
AlloCAR T™ Studies Resumed and Currently Enrolling Patients Following Removal of Clinical Hold in January 2022Phase 1 Data from the…
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 23,…
TOKYO and XIAMEN, China, Feb. 23, 2022 (GLOBE NEWSWIRE) — Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and…
LYON, France, Feb. 23, 2022 (GLOBE NEWSWIRE) — Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specialized in…
October – December Net sales amounted to 2.4 (0.3) MSEKThe operating result for the period was -8.9 (-12.5) MSEKThe net…